INSTRUCTIONS FOR ABSTRACT SUBMISSION
(Deadline for Abstract Submissions is December 3, 2018 at 12 Noon EST)

ACL Research Retreat VIII
March 14 – 16, 2019
Greensboro, North Carolina

MEETING DETAILS:
The format will feature presentations by well-known experts in the field, as well as 15-minute podium presentations, 3 minute rapid-fire presentations and poster presentations of research relating to non-contact ACL injury and post-traumatic osteoarthritis epidemiology, risk factor identification, and prevention. Significant time will be provided for group discussion following each keynote and each group of podium presentations. At the conclusion of the meeting our goal will be to revisit and update the consensus statement from the 2015 research retreat and set sights on future research directions based on progress.

CONTENT:
NEW! - We are expanding the 2019 Retreat to include post traumatic (ACL injury) osteoarthritis, as there is much we can learn from ACL-Injured in terms of future ACL injury risk and subsequent quality of life outcomes and post OA development.

All abstracts must be original research not previously presented, and be related to non-contact ACL injury Appropriate topics include epidemiology, risk factor identification (i.e. anatomical, biomechanical, neuromuscular, hormonal, etc), and prevention of both non-contact ACL injury as well as post-traumatic osteoarthritis.

***Abstracts previously presented or accepted for presentation elsewhere will not be accepted.***

FORMAT:
Please see next page for full instructions.

SUBMISSION:
An original and one blinded copy of the abstract (authors and affiliations removed) with ‘First author’s last name initials - ACL Retreat Abstract’ (eg. Smith AB – ACL Retreat Abstract) in the subject line should be emailed to: anrl@uncg.edu

Abstracts are due December 3, 2018 at 12 Noon EST. Abstracts will be blind reviewed for both content and scientific merit and will be considered for 15-minute podium presentations, 3 minute rapid-fire presentations and poster presentations. Notification of acceptance will be given to authors no later than Dec 19, 2018. If you do not wish your abstract to be considered as an oral presentation (i.e. considered as poster only), please designate this in your email correspondence.

For more information regarding abstract submission, please contact:
Randy Schmitz PhD ATC
rjschmit@uncg.edu

Complete information on the Meeting can be found online at:
https://kin.uncg.edu/research/labs/a...at-index-html/



Instructions for Preparation of Abstracts
(ABSTRACT SUBMISSION DEADLINE: December 3, 2018 at 12 Noon EST)

Please read all instructions before preparing and submitting the abstract. An individual may submit only one abstract as the primary (presenting) author but may submit unlimited abstracts as a contributing author. All abstracts will undergo blind review. All presentations should be of original work and not previously published.

Prepare your abstract in accordance with the following instructions. Abstracts that do not comply with this format will be returned and not considered for acceptance.

1. Top, bottom, right, and left margins of the body of the abstract (in a WORD file) should be set at 1" using the standard 8.5" x 11" format. Use either Arial or Helvetica 12pt. font with single spacing. Provide the title of the paper or project starting at the top left margin.

2. On the next line, indent 3 spaces and provide the names of all authors, with the author who will make the presentation listed first. Enter the last name, then initials (without periods), followed by a comma, and continue the same format for all secondary authors (if any), ending with a colon.

3. On the same line following the colon, indicate the name of the institution (including the city and state) where the research was conducted. If primary author is not at the institution where the work was completed place an * after their name and following the institution where the research was conducted the primary author can indicate their present institution (including the city and state). For collaborative projects where portions of the project were conducted at different institutions, list all authors as described above (#3), then list institutional affiliations using the following consecutive symbols (*, †, ‡, §, ║, ¶, #, **, etc.) See example below

4. Double space and begin entering the body of the abstract flush left in a single paragraph with no indentions. The text of the body must be structured (with the headings as indicated in the various formats below). Do not justify the right margin. Do not include tables or figures. The body of the abstract is limited to 450 words. A word count generated by MS Word must be included at the bottom of the abstract. The word count should include the body of the abstract and structured headings.

5. The required formats for the structured abstract are as follows. For further clarification, authors should consult the AMA Manual of Style 9th edition.


Format for Basic Research Abstracts

The Title of your Abstract Bolded and in Title Case

[3 spaces] Doe JT*, Public JQ†: *First Author's Institution Name, †Second Author's Institution.
[Blank Line] [Blank Line]
Context: Write a sentence or two summarizing the rationale for the study, providing a reason for the study question and/or uniqueness of study. Objective: State the precise objective(s) or question(s) addressed in the report, including a priori hypotheses if applicable. Design: Describe the overall study design of the project reported (e.g., randomized controlled trial, crossover trial, cohort or cross-sectional). Setting: Describe the environment in which the study was conducted to help readers understand the transferability of the findings, (e.g., patient clinic, research laboratory or field). Patients or Other Participants: Describe the underlying target population, selection procedures (e.g., population based sample, volunteer sample or convenience sample) and important aspects of the final subject pool (e.g., number, average age, weight, height and measures of variance, years of experience or gender). Appropriate sample size should be evident. Interventions: Interventions are the independent variables in the study. Describe the essential pieces of the experimental methods, types of materials, measurements and instrumentation utilized, data analysis procedures and statistical tests employed. Provide validity and reliability information on novel instrumentation. Main Outcome Measures: Clearly identify primary or critical dependent variables that support the primary objective(s) of the study. Indicate the statistical analysis employed to answer the primary research objective(s).Results: The main results of the study should be given. Comparative reports must* include descriptive data (e.g., proportions, means, rates, odds ratios or correlations), accompanying measures of dispersion (e.g., ranges, standard deviations or confidence intervals) and inferential statistical data. Results should be accompanied by the exact level of statistical significance. The P value should not exceed 3 digits to the right of decimal. When the exact significance is below P < .001, the exact significance should be reported as P < .001. Conclusions: Summarize or emphasize the new and important findings of the study. The conclusion must be consistent with the study objectives and results as reported and should be no more than three to four sentences. If possible, relate implications of the findings for clinical practice. Word Count: Limited to 450 words including headings.

* The purpose of having both descriptive and inferential data is that it provides the reader with the ability to judge the concluding statements. Descriptive data provides confidence that the data are ‘reliable’ and provides a gauge to determine whether the inferential statistics and conclusions are meaningful. Studies reporting analysis of larger data bases with multiple variables do not need to report all descriptive data, but should provide descriptive data for those variables which the author(s) believe to be the primary outcome(s) and support the overall conclusions of the study.

Format for Meta-Analysis and Systematic Reviews

The Title of your Abstract Bolded and in Title Case

[3 spaces]Doe JT*, Public JQ†: *First Author's Institution Name, †Second Author's Institution.
[Blank Line]
[Blank Line]
Context: Write a sentence or two summarizing the rationale for the study, providing a reason for the study question. Objective: State the precise objective(s) or question(s) addressed in the report, including a priori hypotheses if applicable. Data Sources: Identify how relevant research papers were identified – include databases and timeframe, key words and search limits. Study Selection: Describe the processes through which studies were selected for inclusion for further analysis. Data Extraction: Identify the number of investigators, the descriptive and measurement data obtained and if and how the quality of study methods was evaluated. Data Synthesis: Describe how the data were organized, the statistical procedures applied (during assessment of heterogeneity) and the results (e.g., effect sizes, odds ratios and 95% confidence intervals) of the analysis. Conclusions: Summarize or emphasize the new and important findingsof the study and relate implications of the findings for future research and/or for clinical practice and offer an indication as to the strength of the evidence provided. The statement of your findings must be consistent with the results as reported. Word Count: Limited to 450 words including headings.